It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Choosing a wide market index fund for retirement involves evaluating diversification, costs, and alignment with your time horizon.
28,206 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
A surprising line in a public financial disclosure turned into a teaching moment for everyday investors. Learn what t...
A July 12 KBW report argues artificial intelligence will fortify the industry’s largest lenders rather than upend the...
CoStar Group appoints Robin Rossmann as chief financial officer, effective July 31, 2026, succeeding Christian Lown. ...
A Fed official signaled no rescue for crypto amid stress, pushing Bitcoin, Ethereum, and XRP into a fresh round of vo...
As existing-home prices hit record highs, builders in 10 U.S. metro areas are offering discounts on new homes. The mo...
Qualcomm's AI data-center push is fueling a fresh round of upside bets, with investors watching for a sustained ramp ...
In the first half of 2026, Vertiv soared as AI data centers pushed demand for cooling and power solutions. This artic...
Austin Niemiec returns to lead Rocket Pro as executives depart, signaling a strengthened wholesale channel amid a vol...
Bitdeer has jumped ahead of MARA in self-mining hash rate among publicly traded miners, a shift highlighted by JPMorg...
Space-based connectivity is drawing attention to AST SpaceMobile. This article analyzes potential price trajectories,...
Tariff policy volatility follows a high court ruling, and a new AI platform aims to help firms weather the disruption...